sb 216763 has been researched along with Hyperlipemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sharma, PL; Singh, M; Yadav, HN | 1 |
1 other study(ies) available for sb 216763 and Hyperlipemia
Article | Year |
---|---|
Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72.
Topics: Animals; Diet, High-Fat; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HSP72 Heat-Shock Proteins; Hyperlipidemias; Indoles; Ischemic Preconditioning, Myocardial; Male; Maleimides; Myocardial Infarction; Myocardium; Organ Culture Techniques; Oximes; Quercetin; Rats; Rats, Wistar; Reperfusion Injury | 2012 |